Latest news
ATS Looks 13.3% Undervalued on GF Value™ as Cost Restructuring D - GuruFocusGuruFocus · Thu, 06 Aug 2026 20:40:20 GMTPfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure - BioSpaceBioSpace · Tue, 04 Aug 2026 13:36:05 GMTAdministration to Pull Back on Premium Help for Part D Beneficiaries - Medicare Rights CenterMedicare Rights Center · Thu, 30 Jul 2026 07:00:00 GMT